ICL670F2201: A randomized, open-label, multicenter, two arm, phase II study to investigate the benefits of an improved deferasirox formulation (film-coated tablet)

Project: Research project

Project Details

StatusFinished
Effective start/end date4/1/143/7/19

Funding

  • Novartis Pharmaceuticals Corporation
  • Novartis Pharmaceuticals Corporation